Raymond James & Associates’s Foley Trasimene Acquisition Corp. II BFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-122,280
Closed -$1.85M 4163
2020
Q4
$1.85M Buy
+122,280
New +$1.39M ﹤0.01% 1931

Other funds holding BFT

Raymond James & Associates's BFT Position: Q1 2021 in Review

Raymond James & Associates sold out of Foley Trasimene Acquisition Corp. II (BFT) in Q1 2021, closing a stake of 122,280 shares — an estimated $1.85M sold.

Raymond James & Associates first reported a position in BFT in Q4 2020 and held it in 1 quarter. The position peaked at $1.85M in Q4 2020. 3 funds tracked by Wall St. Rank hold BFT as of Q1 2021.

  • Raymond James & Associates reported no remaining Foley Trasimene Acquisition Corp. II position as of Q1 2021 after selling out during the quarter.
  • Raymond James & Associates sold 122,280 Foley Trasimene Acquisition Corp. II shares in Q1 2021, an estimated $1.85M.
  • Raymond James & Associates first reported a position in Foley Trasimene Acquisition Corp. II in Q4 2020 and held it in 1 quarter.
  • Raymond James & Associates's Foley Trasimene Acquisition Corp. II position peaked at $1.85M in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Foley Trasimene Acquisition Corp. II as of Q1 2021.

Based on Raymond James & Associates's 13F filing for Q1 2021, filed 14 May 2021.